Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Quest Research Institute, Lake Mary, Florida Velocity Clinical Research, Durham, North Carolina Australia
CMAX, Adelaide, South Australia Monash, Melbourne, Victoria